Helicobacter pylori-specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18. (Q41448198)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

title

Helicobacter pylori-specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

2 March 2020

main subject

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

Sabine Spath

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

6

Burkhard Becher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Daniela B Engler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

Mara L Hartung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

Andreas Kyburz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

Anne Müller

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

Gerhard Rogler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

1 reference

1 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

854-861

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

Inflammatory bowel disease

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

The role of microbes in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Top-down or step-up treatment in Crohn's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Moving towards disease modification in inflammatory bowel disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Trichuris suis therapy in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Helicobacter pylori infection and the risk of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Meta-analysis of the relationship between cagA seropositivity and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

The association between asthma and Helicobacter pylori: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Helicobacter pylori γ-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Adenovirus early region 3(E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

The CD4 T cell-mediated IFN-gamma response to Helicobacter infection is essential for clearance and determines gastric cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Phenotypically distinct subsets of CD4 T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

The MUC2 gene product: a human intestinal mucin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Controlling the frontier: regulatory T-cells and intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Genetic polymorphisms in the IL-18 gene and ulcerative colitis risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: mucosal crosstalk between stomach and distal intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

Helicobacter pylori-induced IL-1β secretion in innate immune cells is regulated by the NLRP3 inflammasome and requires the cag pathogenicity island

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1097/MIB.0000000000000318

10.1097/MIB.0000000000000318

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742401 AND SRC:MED&resulttype=core&format=json

2 March 2020

1 reference